BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18225537)

  • 1. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2007; 27(6B):3813-8. PubMed ID: 18225537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
    Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
    Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.
    Gower WR; Vesely BA; Alli AA; Vesely DL
    Int J Gastrointest Cancer; 2005; 36(2):77-87. PubMed ID: 16648657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
    Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
    Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
    Bell EN; Tse MY; Frederiksen LJ; Gardhouse A; Pang SC; Graham CH; Siemens DR
    J Urol; 2007 Feb; 177(2):751-6. PubMed ID: 17222675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four peptides decrease the number of human pancreatic adenocarcinoma cells.
    Vesely BA; McAfee Q; Gower WR; Vesely DL
    Eur J Clin Invest; 2003 Nov; 33(11):998-1005. PubMed ID: 14636304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
    Skelton WP; Pi GE; Vesely DL
    Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
    Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
    Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptides: anticancer agents.
    Vesely DL
    J Investig Med; 2005 Nov; 53(7):360-5. PubMed ID: 16297362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
    Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.
    Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
    Cancer Lett; 2007 Aug; 254(1):94-101. PubMed ID: 17399891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
    Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
    In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
    Saba SR; Garces AH; Clark LC; Soto J; Gower WR; Vesely DL
    J Histochem Cytochem; 2005 Aug; 53(8):989-95. PubMed ID: 15879575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.